BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 25461996)

  • 1. Chronic lymphocytic leukemia: a clinical review.
    Nabhan C; Rosen ST
    JAMA; 2014 Dec; 312(21):2265-76. PubMed ID: 25461996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic lymphocytic leukemia.
    Byrd JC; Stilgenbauer S; Flinn IW
    Hematology Am Soc Hematol Educ Program; 2004; ():163-83. PubMed ID: 15561682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Prognosis in Chronic Lymphocytic Leukemia in the Contemporary Era.
    Nabhan C; Raca G; Wang YL
    JAMA Oncol; 2015 Oct; 1(7):965-74. PubMed ID: 26181643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.
    Hallek M
    Am J Hematol; 2013 Sep; 88(9):803-16. PubMed ID: 23720127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lymphocytic leukemia: a clinical review including Korean cohorts.
    Jeon YW; Cho SG
    Korean J Intern Med; 2016 May; 31(3):433-43. PubMed ID: 27044858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of pharmacologic options for previously untreated chronic lymphocytic leukemia.
    Wilhelm K; Yang D
    J Oncol Pharm Pract; 2011 Jun; 17(2):91-103. PubMed ID: 20085962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.
    Hallek M
    Am J Hematol; 2015 May; 90(5):446-60. PubMed ID: 25908509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing and treating chronic lymphocytic leukemia in 2009.
    Kaufman M; Rubin J; Rai K
    Oncology (Williston Park); 2009 Nov; 23(12):1030-7. PubMed ID: 20017285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Front-line therapy for chronic lymphocytic leukemia.
    Desai S; Pinilla-Ibarz J
    Cancer Control; 2012 Jan; 19(1):26-36. PubMed ID: 22143060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
    Dennie TW; Kolesar JM
    Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current approach to diagnosis and management of chronic lymphocytic leukemia.
    Shanafelt TD; Call TG
    Mayo Clin Proc; 2004 Mar; 79(3):388-98. PubMed ID: 15008611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
    Maddocks K; Jones JA
    Semin Oncol; 2016 Apr; 43(2):251-9. PubMed ID: 27040703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of front-line therapy with fludarabine-cyclophosphamide-rituximab regimen for chronic lymphocytic leukemia outside clinical trials: the Israeli CLL Study Group experience.
    Herishanu Y; Goldschmidt N; Bairey O; Ruchlemer R; Fineman R; Rahimi-Levene N; Shvidel L; Tadmor T; Ariel A; Braester A; Shapiro M; Joffe E; Polliack A;
    Haematologica; 2015 May; 100(5):662-9. PubMed ID: 25661442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in the front-line management of chronic lymphocytic leukemia.
    Nabhan C; Shanafelt TD; Kay NE
    Leuk Res; 2008 May; 32(5):679-88. PubMed ID: 18191201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Lymphocytic Leukemia: A Review of Front-line Treatment Options, With a Focus on Elderly CLL Patients.
    O'Reilly A; Murphy J; Rawe S; Garvey M
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):249-256. PubMed ID: 29477297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and management of chronic lymphocytic leukemia in the elderly: what the pharmacist clinician should know.
    Johnson TM
    Consult Pharm; 2012 Apr; 27(4):274-85. PubMed ID: 22498987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial therapy of chronic lymphocytic leukemia.
    Eichhorst B; Cramer P; Hallek M
    Semin Oncol; 2016 Apr; 43(2):241-50. PubMed ID: 27040702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.